Pacientes com diabetes tipo 2 e enfermidades associadas, como aterosclerose, insuficincia cardaca ou doena renal crnica
As per diabetes guidelines, it is essential to maintain an HbA1c of less than 7% to reduce the risk of microvascular and macrovascular diabetes complications
A small subset of patients (approximately 47% in clinical trials) discontinue semaglutide due to intolerable gastrointestinal side effects that do not adequately resolve
It causes fullness to set in sooner and last longer
These include semaglutide injections, tirzepatide, oral semaglutide pills, and orforglipron
Patients taking Mounjaro were three times more likely to lose 15% of their body weight and over two and a half times more likely to lose 10% of their body weight than those taking Ozempic or Wegovy, the analysis found